Switching between Three Types of Mesalazine Formulation and Sulfasalazine in Patients with Active Ulcerative Colitis Who Have Already Received High-Dose Treatment with These Agents
2019 · Journal of Clinical Medicine · 19 citations
https://doi.org/10.3390/jcm8122109